drugset / Trial / NCT05619328
A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to investigate the efficacy of the Test Product in subjects with clinically diagnosed peripheral sensory polyneuropathy of different etiologies compared to placebo.
Timeline
- Start
- 2022-09-06
- Primary completion
- 2023-11-02
- Completion
- 2023-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | B1 | Unknown | 100 mg | Oral |
| Subject | B12 | Other / unclassified | 5 mg | Oral |
| Subject | B6 | Other / unclassified | 100 mg | Oral |